Self-regulation of UK's pharmaceutical industry
(2025) In BMJ (Clinical research ed.) 389. p.1065-1065- Abstract
- Industry body’s decision to accept Novo Nordisk back reflects systemic failures
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/ec6fd917-bd2d-496c-b951-af2f79f24b08
- author
- Ozieranski, Piotr ; Mulinari, Shai LU ; Colombo, Cinzia and Mintzes, Barbara
- organization
- publishing date
- 2025-05-28
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMJ (Clinical research ed.)
- volume
- 389
- pages
- 1065 - 1065
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:40436600
- scopus:105006644204
- ISSN
- 1756-1833
- DOI
- 10.1136/bmj.r1065
- project
- Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations
- language
- English
- LU publication?
- yes
- id
- ec6fd917-bd2d-496c-b951-af2f79f24b08
- date added to LUP
- 2025-06-03 16:20:26
- date last changed
- 2025-07-08 06:55:42
@misc{ec6fd917-bd2d-496c-b951-af2f79f24b08,
abstract = {{Industry body’s decision to accept Novo Nordisk back reflects systemic failures}},
author = {{Ozieranski, Piotr and Mulinari, Shai and Colombo, Cinzia and Mintzes, Barbara}},
issn = {{1756-1833}},
language = {{eng}},
month = {{05}},
pages = {{1065--1065}},
publisher = {{BMJ Publishing Group}},
series = {{BMJ (Clinical research ed.)}},
title = {{Self-regulation of UK's pharmaceutical industry}},
url = {{http://dx.doi.org/10.1136/bmj.r1065}},
doi = {{10.1136/bmj.r1065}},
volume = {{389}},
year = {{2025}},
}